openPR Logo
Press release

Investigation announced for Investors in Inotiv, Inc. (NASDAQ: NOTV) over potential Wrongdoing

04-10-2023 10:55 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of investors in Inotiv, Inc. (NASDAQ: NOTV) shares over potential wrongdoing at Inotiv, Inc.

An investigation on behalf of investors in Inotiv, Inc. (NASDAQ: NOTV) shares over potential wrongdoing at Inotiv, Inc.

An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Inotiv, Inc.

Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Inotiv, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.

West Lafayette, IN based Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. Inotiv, Inc reported that its Total Revenue rose from $60.46 million to $89.6 million for the 12 months period that ended on September 30, 2020, and that its Net Loss over those respective time periods increased from $1.49 million to $1.68 million.
According to Seeking Alpha, on May 23, 2022, it was disclosed that a DOJ-backed lawsuit was initiated against a subsidiary of Inotiv, Inc. The legal action is for alleged violations of animal welfare.

On November 17, 2022, in a Form 8-K filed with the United States ("U.S.") Securities and Exchange Commission, Inotiv, Inc. disclosed that, on November 16, 2022, the Company became aware that the U.S. Attorney's Office for the Southern District of Florida criminally charged employees of the Company's principal supplier of non-human primates ("NHPs") with conspiring to illegally import NHPs into the U.S. from December 2017 through January 2022 and in connection with seven specific imports between July 2018 and December 2021.

Shares of Inotiv, Inc (NASDAQ: NOTV) declined from $19.01 per share on May 18, 2022, to as low as $4.04 per share on April 6, 2023.

Those who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in Inotiv, Inc. (NASDAQ: NOTV) over potential Wrongdoing here

News-ID: 3006795 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with shares of Revance Therapeutics, Inc …
An investor, who purchased shares of Revance Therapeutics, Inc. (NASDAQ: RVNC), filed a lawsuit over alleged violations of Federal Securities Laws by Revance Therapeutics, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) between February 29, 2024 and December 6, 2024, and / or those who purchased anyNASDAQ: RVNC shares prior to February 2024 and continue
Lawsuit filed for Investors who lost money with shares of AstraZeneca PLC (NASDAQ: AZN)
Lawsuit filed for Investors who lost money with shares of AstraZeneca PLC (NASDA …
An investor, who purchased shares of AstraZeneca PLC (NASDAQ: AZN), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by AstraZeneca PLC in connection with certain allegedly false and misleading statements made between February 23, 2022 and December 17, 2024. Investors who purchased a significant amount of shares of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and December 17, 2024, have certain options and for certain
Lawsuit filed for Investors who lost money with shares of Applied Therapeutics, Inc. (NASDAQ: APLT)
Lawsuit filed for Investors who lost money with shares of Applied Therapeutics, …
An investor, who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT), filed a lawsuit over alleged violations of Federal Securities Laws by Applied Therapeutics, Inc. Investors who purchased shares of Applied Therapeutics, Inc. (NASDAQ: APLT) have certain options and for certain investors are short and strict deadlines running. Deadline: February 18, 2025. NASDAQ: APLT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. New York based Applied
Investigation announced for Long-Term Investors in shares of WEBTOON Entertainment Inc. (NASDAQ: WBTN) over possible Wrongdoing
Investigation announced for Long-Term Investors in shares of WEBTOON Entertainme …
An investigation on behalf of current long-term investors in shares of WEBTOON Entertainment Inc. (NASDAQ: WBTN) concerning potential breaches of fiduciary duties by certain directors of WEBTOON Entertainment Inc. was announced. Investors who are current long term investors in WEBTOON Entertainment Inc. (NASDAQ: WBTN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long

All 5 Releases


More Releases for Inotiv

Deadline on August 22nd coming up in Lawsuit for Investors in Inotiv, Inc. (NASD …
A deadline is coming up on August 22, 2022 in the lawsuit filed for certain investors of Inotiv, Inc. (NASDAQ: NOTV) over alleged securities laws violations by Inotiv, Inc. Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and there are strict and short deadlines running. Deadline: August 22, 2022. NASDAQ: NOTV stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to the
Lawsuit filed for Investors in shares of Inotiv, Inc. (NASDAQ: NOTV)
An investor, who purchased shares of Inotiv, Inc. (NASDAQ: NOTV), filed a lawsuit over alleged Securities Laws violations by Inotiv, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV) have certain options and for certain investors are short and strict deadlines running. Deadline: August 22, 2022. NASDAQ: NOTV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Computational Predictive Toxicology Modeling Service Market Research New Report …
The Computational Predictive Toxicology Modeling Service market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge
Computational Predictive Toxicology Modeling Service Market Analysis by Size, De …
The "Computational Predictive Toxicology Modeling Service Market" research report is an intelligence report that has been meticulously compiled to find relevant and valuable information. The data studied is designed with the best existing players and future competitors. The key player's business strategies and new market industries are studied in detail. The report makes future forecasts based on an analysis of market fragmentation, including product categories, end-user applications and Computational Predictive
Computational Toxicology Solutions Market Analysis, Promising Growth Opportuniti …
Los Angeles, United States,- This research study is one of the most detailed and accurate ones that solely focus on the global Computational Toxicology Solutions market. It sheds light on critical factors that impact the growth of the global Computational Toxicology Solutions market on several fronts. Market participants can use the report to gain a sound understanding of the competitive landscape and strategies adopted by leading players of the global
Investigation announced for Investors in shares of Inotiv, Inc. (NASDAQ: NOTV)
An investigation was announced concerning potential securities laws violations by Inotiv, Inc. in connection with certain financial statements. Investors who purchased shares of Inotiv, Inc. (NASDAQ: NOTV), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Inotiv, Inc. regarding its business, its prospects and its operations were materially false and